MedTrace Logo

Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care

NCT06325384 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-04-03

No results posted yet for this study

Summary

A randomised controlled trial for comparison of real-world feasibility and clinical outcomes of two different methods of home blood pressure monitoring Participants aged 18 years or over with diagnosed and treated hypertension (including via lifestyle interventions) that is not controlled (i.e. in-clinic measurement is 140/90 mmHg or greater) will be recruited from hypertension hospital clinics

Conditions

Interventions

DEVICE

Lifelight

Contactless Vital Signs Measurement via RPPG

DEVICE

Blood Pressure Cuff

Standard Blood Pressure Cuff Digital

Sponsors & Collaborators

  • Barts & The London NHS Trust

    collaborator OTHER

  • Mind Over Matter Medtech Ltd

    collaborator INDUSTRY

  • Health Innovation Wessex

    collaborator UNKNOWN

  • Xim Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06325384 on ClinicalTrials.gov